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T he myocardium is highly organized tissue, composedof several cell types that include smooth muscle cells,
fibroblasts, and cardiac myocytes. The fundamental con-
tractile cell of the myocardium is the myocyte. The pur-
pose of this review is to examine the structural components
of the myocyte and then to place these components into a
functional context with respect to the contractile process.
Basement membrane
The first boundary encountered when moving from the
extracellular space to the intracellular space of the
myocyte is the basement membrane. The basement mem-
brane is composed primarily of type IV collagen, the gly-
coproteins laminin and fibronectin, and proteoglycans.1
The basement membrane provides an interface to the fib-
rillar collagen matrix of the extracellular space with
anchoring fibers, which bind the basal lamina to under-
lying collagen. The function of the basement membrane
is to provide an initial barrier that will influence the
exchange of macromolecules between the extracellular
space and the myocyte. Another important function of
the basement membrane is to provide an interface for
myocyte adhesion and continuity with the extracellular
matrix. An illustration of the organization of the pertinent
structures of the cardiac myocyte is shown in Fig 1. 
Sarcolemma 
A specialized structure of the myocyte is the sar-
colemma, a coalescence of the plasma membrane prop-
er and the basement membrane. The sarcolemma is
composed of a lipid bilayer, which contains hydrophilic
heads and hydrophobic tails. This configuration allows
the sarcolemma to interact with the intracellular and
extracellular environment, but a hydrophobic core
results in the sarcolemma being impermeable to
charged molecules. Interwoven throughout the sar-
colemma are integrins, which, with receptor transmem-
brane proteins, bind the myocyte to the extracellular
matrix and basement membrane. More important, inte-
grins attach to the intracellular side of the sarcolemma,
forming an important collagen-integrin-cytoskeletal
relation.2 It has been postulated that integrin engage-
ment to the extracellular and intracellular spaces is an
essential component for the transduction of myocyte
shortening into an overall ventricular ejection.2
The sarcolemma forms 2 specialized regions of the
myocyte, the intercalated disks and the transverse tubu-
lar system. The intercalated disks are a specialized cell-
cell junction, which serves both as a strong mechanical
linkage between myocytes and as a path of low resis-
tance that allows for rapid conduction of the action
potential between myocytes.3 Transverse tubules, or T
tubules, are invaginations of the sarcolemma into the
myocyte, which form a barrier between the intracellular
and extracellular spaces. These extensions bring in
close apposition the L-type Ca2+ channel and the sar-
coplasmic reticulum Ca2+ discharge system, thus mak-
ing the T-tubular system an important structural compo-
nent in excitation-contraction coupling.
As with most lipid bilayers, the fundamental function
of the sarcolemma is to provide a barrier for diffusion.
The sarcolemma also contains membrane proteins,
which include receptors, pumps, and channels. This is a
specialized feature of the sarcolemma and is essential to
the contractile process of the myocyte. Presented below
is an overview of the sarcolemmal proteins that are
essential to the propagation of the myocyte action poten-
tial and, therefore, fundamental to the contractile process.
Sarcolemmal pumps and ion channels. A useful
paradigm to review the pumps and channels of the
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myocyte sarcolemma is to place it in the context of the
phases of the action potential. A representative ventric-
ular myocyte action potential is shown in Fig 2. The
resting membrane potential, or phase 4 of the action
potential, is maintained primarily by the inward K+ rec-
tifier and is secondarily influenced by the Na+/K+
adenosinetriphosphatase (ATPase), the Na+/Ca2+
exchanger, and the sarcolemmal Ca2+ ATPase. During
this phase, the sarcolemma is permeable only to K+;
thus it is the K+ equilibrium potential that primarily
determines the resting membrane potential of the
myocyte. The inward K+ rectifier allows for K+ diffu-
sion into the myocyte. The Na+/K+ ATPase generates a
net outward current through the extrusion of three Na+
ions for two K+ ions, as well as being the site for digi-
talis binding. The Na+/Ca2+ exchanger and the sar-
colemmal Ca2+ ATPase provide the basis for Ca2+
extrusion from the myocyte. The Na+/Ca2+ exchanger is
a bidirectional channel, with the relative amounts of
either ion carried across the membrane determined by
the concentrations on either side of the membrane.4
However, the Na+/Ca2+ exchanger is the primary sys-
tem for Ca2+ efflux from the myocyte.4-6 Through the
removal of cytosolic Ca2+, the balance of Ca2+ efflux
and influx can be maintained, contributing to the main-
tenance of the resting potential.
The fast Na+ channel is responsible for the rapid
upstroke of phase 0 of the action potential. When the
membrane potential achieves a preset threshold volt-
age, the Na+ channels rapidly activate (<1 ms) and
remain activated for a duration of only 2 to 10 ms; thus
the name “fast” Na+ channel. The activation of these
channels allow Na+ to flow into the cell along both
electrical and chemical concentration gradients. This
influx of Na+ through the fast Na+ channel puts into
motion the ionic processes responsible for the other
phases of the action potential.
Rapid inactivation of the Na+ channels and slower
activation of two outward currents are the bases for
early repolarization. The positive membrane potential,
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Fig 1. Longitudinal cross section of an individual cardiac myocyte. The sum of the integral parts of the cardiac
myocyte are shown here, moving from outward in. The basement membrane, which is composed of collagen, gly-
coproteins, and proteoglycans, provides an interface for myocyte adhesion, as well as continuity with the extra-
cellular matrix. The basement membrane serves as an anchoring site for the collagen fibrils. The sarcolemma,
which enfolds the myocyte, contains integrins that bind the myocyte to the extracellular matrix, and also contains
integral proteins that contribute to the action potential. Invaginations of the sarcolemma, which contains a high
density of L-type Ca2+ channels, are the T tubules. This specialized region of the sarcolemma allows for the close
apposition of the L-type Ca2+ channel to the Ca2+ release channels of the sarcoplasmic reticulum. The sarcoplas-
mic reticulum serves both as a source and an internal store of cytosolic Ca2+ required for excitation-contraction
coupling. The contractile apparatus is a highly organized array of myofilament proteins composed primarily of
thick myosin and thin actin filaments. The overlapping of these proteins form the dark and light bands as shown
in this illustration. Cut in cross section are shown the numerous mitochondria, which are in close proximity to the
myofilament apparatus. 
the Cl– concentration gradient, and increased membrane
permeability to Cl- allows for the entry of Cl– into the
cell. In addition, a transient efflux of K+ through specif-
ic channels occurs along the K+ electrochemical gradi-
ent. The combination of these three events contributes
to a brief and small repolarization of the membrane
potential during phase 1 of the action potential.
The cardiac action potential plateau, or phase 2, is pri-
marily determined by the influx of Ca2+ through the L-
type Ca2+ channels.7,8 In addition, a counterbalancing
outward K+ current flows through the “anomalous” K+
rectifier.3 Both of these channels are activated during
the upstroke of the action potential and reach peak cur-
rent concurrently during the plateau phase. L-type Ca2+
channels are intimately involved in excitation-contrac-
tion coupling, which will be discussed in a later section.
Phase 3 or repolarization is the result of increased K+
conductance through the delayed rectifier K+ channels.
These channels are activated toward the end of the
plateau phase and allow K+ ions to flow along the con-
centration gradient. All other inward currents, Na+ and
Ca2+, are inactivated, thus making the delayed rectify-
ing K+ current responsible for the restoration of the
membrane potential to the resting state. By means of an
adenovirus transfer method, increased gene expression
for the K+ channel has been induced in adult ventricu-
lar myocyte preparations.9 Increased expression of the
K+ channel resulted in significant shortening of phase 3
of the action potential and abbreviated the excitation-
contraction coupling process. 
Sarcolemmal receptor systems. Receptor systems
that have been identified in the myocyte include the
muscarinic, a , and endothelin receptor systems.10-12
However, one of the more important receptor systems
of the myocyte is the b -adrenergic system, because
modulation of this receptor transduction system is
commonly used in clinical practice. For the purposes of
this review, the b -adrenergic receptor system can serve
as a prototypical sarcolemmal receptor transduction
system. The b -adrenergic receptor system exists in
both activated and inactivated states. Under ambient
conditions, both forms are in equilibrium, but the inac-
tivated state is predominant.13,14 Endogenous cate-
cholamines and synthetic b -adrenergic agonists bind to
the b -adrenergic receptor, resulting in a 3-dimensional
conformational change of the receptor. This begins
with the binding and activation of a guanine
nucleotide–dependent coupling protein, resulting in
adenylate cyclase stimulation and subsequent increases
in cyclic adenine monophosphate production. Through
the binding of the regulatory subunit, cyclic adenine
monophosphate stimulates the active catalytic subunits
of protein kinase A, which in turn phosphorylates spe-
cific sites within the myocyte to modify their activi-
ty.15-17 Three phosphorylation sites relevant to the exci-
tation-contraction coupling process are the
sarcolemmal L-type Ca2+ channel, the sarcoplasmic
reticulum regulatory protein, phospholamban, and tro-
ponin I of the myocyte contractile apparatus. In a study
by Bittner and associates,18 transgenic mice were cre-
ated with specific myocardial overexpression of the
human b -adrenergic receptor. These mice exhibited
increased basal myocardial adenylate cyclase activity,
which translated into enhanced left ventricular contrac-
tility. In addition, Rockman and coworkers19 found that
the overexpression of the b -adrenergic receptor result-
ed in markedly enhanced myocardial relaxation, as
well as a reduction in the levels of the sarcoplasmic
protein phospholamban. These genetic models empha-
size the importance of the b -adrenergic receptor trans-
duction system in the modulation of the myocyte exci-
tation-contraction coupling process.
Myocyte cytoskeleton
The cytoskeleton of the myocyte forms an important
structural interface with the extracellular environment
and the contractile apparatus.20-22 Specifically, a num-
ber of cytoskeletal proteins such as a -actinin, talin, and
desmin converge at the site where integrins enter the
cytosolic compartment. A number of these cytoskeletal
proteins can be phosphorylated and thereby change
structural conformation, which in turn can influence
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Fig 2. A schematic of a ventricular myocyte action potential.
The regenerative cardiac action potential consists of 5 phas-
es. Phase 0, the upstroke, corresponds to rapid depolarization.
The upstroke is followed by phase 1, a brief early repolariza-
tion, phase 2 or plateau, phase 3 or rapid repolarization, and
phase 4, which corresponds to the resting membrane poten-
tial. This action potential is the result of sarcolemmal protein
interactions that have been summarized in the text.
myocyte geometry and function. Moreover, large
cytoskeletal proteins such as titin provide viscoelastic
properties to the myocyte and have been postulated to
prevent overstretch of the myofilament apparatus.23,24
Fig 3 presents representative photomicrographs of a
normal myocyte after immunofluorescent staining for
the cytoskeletal proteins desmin and titin. Other impor-
tant cytoskeletal proteins include the tubulins.
Specifically, a - and b -tubulin participate in myofibril-
lar assembly and the transduction of mechanical signals
to the nuclear envelope.25 More recently, it has been
demonstrated that the density and organization of b -
tubulin within the myocyte may directly influence
myocyte contractile performance.26 Thus, although the
cytoskeleton has been historically considered to be a
static component of the myocyte, it is very likely that
the complex interaction of cytoskeletal proteins direct-
ly affect the form and function of the myocyte.
Sarcoplasmic reticulum
The sarcoplasmic reticulum, an intracellular mem-
brane network, is a highly efficient Ca2+ handling
organelle, specialized for the regulation of cytosolic
Ca2+ concentration.27,28 It forms specialized structural
regions of the myocyte in close apposition with the sar-
colemma, particularly, the T tubular system.29 The sar-
coplasmic reticulum, responsible for the Ca2+ source in
excitation-contraction coupling,15 contains three
important components that participate in the role of this
organelle with respect to Ca2+ homeostasis: the sar-
coplasmic reticulum Ca2+ ATPase (SERCA-2), the reg-
ulatory protein of SERCA-2, phospholamban, and the
Ca2+ release channel. 
Sarcoplasmic reticulum proteins. SERCA-2, an
ATP-dependent Ca2+ pump distinct from that found in
the sarcolemma, is a fundamental determinant of Ca2+
accumulation within the myocyte.3 For every 1 mol of
ATP hydrolyzed, 2 mol of Ca2+ is transported back into
the sarcoplasmic reticulum, thereby decreasing cytoso-
lic Ca2+.30,31 In conjunction with the Na+/Ca2+ exchang-
er and sarcolemmal Ca2+ ATPase, the uptake of Ca2+ by
SERCA-2 forms the basis by which cytosolic Ca2+ can
be altered by more than 100-fold during the excitation-
contraction coupling process.16 Phospholamban, co-
localized with SERCA-2,32 has only recently been rec-
ognized as an important regulatory protein for
SERCA-2 function. When phosphorylated, phospho-
lamban facilitates SERCA-2 uptake into the sarcoplas-
mic reticulum, whereas dephosphorylation of phospho-
lamban results in decreased sensitivity of SERCA-2 to
cytosolic Ca2+.28 Thus the phosphorylated state of phos-
pholamban plays a critical role in the rate and extent of
Ca2+ removal from the cytosolic compartment. Using a
genetically engineered mouse model, in which endoge-
nous phospholamban had been increased by more than
2-fold, important changes in the Ca2+ uptake process
were observed.33 Specifically, a reduction in the affinity
of SERCA-2 for Ca2+ occurred and caused a decline in
the magnitude of the Ca2+ signal.33 These changes in
SERCA-2 function with phospholamban overexpres-
sion were translated into diminished active relaxation of
the myocyte.33 Thus phospholamban plays a critical
role in the regulation of Ca2+ uptake in the sarcoplasmic
reticulum, which in turn regulates the fundamental
process of excitation-contraction coupling. The calcium
release channel is found in dense populations at the
interface between the sarcoplasmic reticulum and the T-
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Fig 3. The cytoskeleton of the myocyte is highly structured
and is composed of a number of proteins that participate in
signal transduction, the maintenance of cell shape, and serve
as a template for contractile element assembly. In this figure,
immunofluorescent images for the cytoskeletal protein
desmin (left panels) and titin (right panels) are shown.
Desmin is an intermediate filament that co-localizes to the Z-
bands of myocytes and has been postulated to provide align-
ment of adjacent myofibrils. The periodicity of desmin with-
in the myocytes can be readily appreciated at high power
(lower left panel). Titin is the largest cytoskeletal protein
identified within the myocyte and plays an important role in
maintaining sarcomere alignment, provides elastic recoil, and
prevents sarcomere overstretch. A doublet pattern for titin can
be appreciated at high power (lower right panel), which inter-
faces on either side of the Z-band at 100 nm intervals. 
tubular system of the sarcolemma.34 This channel, also
called the ryanodine receptor channel,15,34,35 is respon-
sible for Ca2+ release from sarcoplasmic reticulum
stores and is very sensitive to small changes in cytoso-
lic Ca2+. A small but rapid influx of Ca2+ through the
Ltype Ca2+ channel will result in an immediate release
of a large bolus of Ca2+ into the myocyte cytosolic
space.3 This large release of Ca2+ from the calcium
release channel is responsible for engaging the contrac-
tile apparatus.34-36
Contractile apparatus
The fundamental contractile unit within the myocyte
is the sarcomere, containing the components of the
contractile apparatus. The sarcomere is composed of
thick and thin interdigitating filaments and has a rest-
ing length of 1.8 to 2.4 m m.16 The fundamental proteins
of the contractile apparatus are myosin, actin, tropo-
myosin, and the troponin complex.16 In the presence of
increased extracellular Ca2+, interactions occur
between these proteins, causing the hydrolysis of ATP
and changes in physical-chemical dynamics. These
processes result in the development of tension within
the myocyte. Myosin, the thick filament, is composed
of a filamentous tail and a globular head region. This
globular head contains the site for actin binding, as
well as a catalyzing site for ATPase activity. Actin is the
major contractile protein found in the thin filament.
Having two forms, G and F, F-actin is the backbone of
the thin filament with G-actin working as a stabilizing
protein. Each G-actin monomer has two myosin bind-
ing sites. The interaction between the myosin globular
head and the G-actin monomer in the presence of ATP
results in crossbridge formation and sarcomere short-
ening. Tropomyosin is another protein found in the thin
filament. This rigid molecule lies on either side of
The Journal of Thoracic and
Cardiovascular Surgery
Volume 118, Number 2
Walker and Spinale   379
Fig 4. A schematic of the components that participate in excitation-contraction coupling in the cardiac
myocyte. The sarcolemma contains a number of ion channels and pumps that contribute to overall Ca2+ levels
within the myocyte. The mechanisms that contribute to removal of Ca2+ from the myocyte include the Na+/Ca2+
exchanger and the sarcolemmal Ca2+-ATPase. The Na+/Ca2+ exchanger is influenced by either ion concentra-
tion and is reversible. The Na+/K ATPase contributes to the extrusion of Na+ and thereby contributes to the
maintenance of the resting membrane potential. With myocyte depolarization, the voltage-sensitive Ca2+ chan-
nel (L-type Ca2+ channel) will become active and result in a Ca2+ current (ICA). The Ca2+ current is a “trigger
current” that will result in activation of the Ca2+ release channel (CRC) on the sarcoplasmic reticulum. The
bolus of Ca2+ released from the Ca2+ release channel results in engagement of the myofilaments and actin-
myosin crossbridge formation. Removal of Ca2+ from the cytosolic space, thereby disengaging crossbridge for-
mations, is intimately dependent on the action of the sarcoplasmic reticulum Ca2+ ATPase (SERCA-2).
(Modified from Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force, Fig 21, 1991: p. 38.
With kind permission from Kluwer Academic Publishers.) 
actin, adding rigidity to the thin filament. Tropomyosin
influences actin-myosin crossbridge formation by
physically interdigitating between the actin-myosin
cleft, thus preventing Ca2+ binding.3 The troponin com-
plex, also present in the thin filament, is composed of
three proteins: troponin T, I, and C. Troponin is an
important component in that it regulates the extent of
crossbridge formation, as well as contributing to the
structural integrity of the sarcomere. Troponin T binds
the troponin complex to tropomyosin and anchors the
complex to the thin filament. Under normal conditions,
phosphorylated troponin I weakens the affinity of Ca2+
for troponin C. Ca2+ binding to troponin C results in a
conformational change of the complex, with subse-
quent actin-myosin interaction, thus initiating cross-
bridge formation.
Mitochondria
The maintenance of high ATP stores is a requirement
of the myocyte. Thus the myocyte is rich in the
organelle essential for this process—the mitochondria.
Mitochondria occupy 40% of myocyte cell volume,3
thus emphasizing the immense energy demands of the
myocyte. Phosphocreatine is a high-energy reserve and
also plays an instrumental role in the shuttling of phos-
phate to the cytosol.3 Because cytosolic phosphocrea-
tine and creatine concentrations are higher than those
of adenosine diphosphate, this serves as a rapid trans-
port system of high-energy phosphate between the
mitochondria and the cytosol. The high-energy phos-
phate of ATP is transferred to phosphocreatine, which
diffuses through the cytosol to be reconverted to ATP
for cell energy use, for example, in excitation-contrac-
tion coupling.3 Mitochondria are also known to have
the capacity to bind and take up large amounts of
cytosolic Ca2+, as well as play a role in the buffering of
cytosolic Ca2+, thus protecting the myocyte from the
effects of Ca2+ overload.3,37
Excitation-contraction coupling
Excitation-contraction coupling refers to the mecha-
nism by which an action potential leads to contraction
of the myocyte. The fundamental ion for inducing the
excitation-contraction coupling complex is Ca2+. The
excitation-contraction coupling complex is achieved
through the increase in cytosolic Ca2+ levels from
nanomolar (100 nmol/L) to micromolar (10 m mol/L)
concentrations.16 Fig 4 presents important components
of the excitation-contraction coupling process. 
Contraction. When an action potential reaches the
myocyte, the wave of depolarization, particularly at the
T-tubular system, results in the activation of sarcolem-
mal voltage-sensitive L-type Ca2+ channels and Ca2+
conductance.7,8 This rapid but small influx of Ca2+
through the L-type Ca2+ channels causes activation of
the Ca2+ release channel, resulting in an immediate
release of large amounts of Ca2+ into the cyto-
sol.7,15,34-36,38,39 The Ca2+ that flows through the L-type
Ca2+ channel is referred to as the trigger Ca2+ cur-
rent.7,16 The absolute amount of trigger Ca2+ is very
small in relation to Ca2+ release from the sarcoplasmic
reticulum; therefore, trigger Ca2+ does not significant-
ly contribute to crossbridge formation. 
After release of Ca2+ from the sarcoplasmic reticu-
lum, a series of interactions occur within the contractile
protein of the sarcomere. For the purposes of this
review, the sliding filament theory will be used to
explain the interaction of the various contractile pro-
teins.3,16,17,40 Under resting conditions, concentrations
of cytosolic Ca2+ are low; phosphorylated troponin I
decreases the affinity of cytosolic Ca2+ for troponin C,
favoring a stronger interaction between troponin I and
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Fig 5. A representative contraction profile of an isolated nor-
mal human left ventricular myocyte stimulated at 1 Hz under
normothermic contractile conditions. A uniform pattern of
contractility can be appreciated. After b -adrenergic receptor
stimulation (25 nm isoproterenol), the extent of myocyte
shortening is significantly increased, consistent with a posi-
tive inotropic response. The increase in contractility that
occurs in response to inotropic stimulation is due to phos-
phorylation of 3 key proteins within the myocyte: the sar-
colemmal L-type Ca2+ channel, the sarcoplasmic reticulum
regulatory protein, phospholamban, and troponin I of the
myocyte contractile apparatus. 
the actin molecule. Therefore the troponin-tropo-
myosin complex is shifted toward the outer grooves of
the actin filament, thus blocking actin-myosin interac-
tion. An increase in cytosolic Ca2+ allows for the bind-
ing of Ca2+ to troponin C, resulting in a shift of tro-
ponin I affinity from the actin filament to troponin C.
The destabilizing of troponin I from the actin molecule
results in a conformational shift of the troponin-
tropomyosin complex away from the actin-myosin
binding site with subsequent crossbridge formation.
After crossbridge formation, the hinge regions in the
crossbridge permit the myosin head to swing toward
the thin filament. After attachment, the myosin head
changes conformation, resulting in the hydrolysis of
ATP. This conformational change in the crossbridge
generates a force moving the thin filament relative to
the thick filament. This crossbridge formation and the
conformation change of the myosin head results in the
hydrolysis of ATP and the binding of a new ATP mole-
cule. The binding of new ATP causes release of the
existing crossbridge and formation of a new one. Each
crossbridge cycle moves the filaments approximately
10 nm with an average velocity of 0.98 m m/s. If the
average sarcomere length is considered to be 1.8
m m,3,38 the speed of sarcomere contraction translates to
5.645 · 10–6 miles per hour. Although this may seem
relatively slow, when velocity is normalized to the ini-
tial sarcomere length, sarcomere velocity is actually
1960 units of distance per hour. This highly dynamic
process is dependent on the number of crossbridges
formed during each contraction, the action potential
duration, the amount of Ca2+ released from the sar-
coplasmic reticulum, and ATP stores. The cycle of
crossbridge formation will continue until the Ca2+ is
removed from the cytoplasm by active, energy-depen-
dent means or by exhaustion of ATP stores.
Active relaxation. Active relaxation is dependent on
the function of SERCA-2. For each 1 mol of ATP
hydrolyzed, 2 mol of Ca2+ is transported back into the
sarcoplasmic reticulum. The function of SERCA-2 and
the regulatory state of phospholamban significantly influ-
ence the active relaxation process within the myocyte.
Other systems, albeit slower, for the removal of Ca2+
from the cytosolic compartment include the Na+/Ca2+
exchanger, the sarcolemmal Ca2+ ATPase, and additional
cytosolic Ca2+ binding proteins including calmodulin and
calsequestrin. The complex formed by the binding of
calmodulin to intracellular Ca2+ can activate the sar-
colemmal Ca2+ ATPase to extrude cytosolic Ca2+.41,42
Calsequestrin binds and internalizes Ca2+ within the
internal cardiac vesicular stores where it is located.27,41 It
is important to emphasize that active relaxation is a high
energy–dependent process, and changes in this phase of
excitation-contraction coupling will be manifest as
changes in myocyte diastolic performance.
Myocyte contractility
The end result of a successfully transduced action
potential and the initiation of Ca2+ release into the
cytosolic compartment of the myocyte is a contraction.
Over the past decade, refinements in isolation meth-
ods,43 culture techniques, and computer acquisition sys-
tems have made it possible to measure contractile func-
tion at the single myocyte level.44,45 The isolated
myocyte provides a measure to examine the modulating
effects of the sarcolemmal receptor systems with respect
to contractile performance in the absence of confound-
ing factors, such as loading conditions and neurohor-
monal activity. For example, the direct effects of b -
adrenergic receptor stimulation, as well as modulating
downstream factors in the b -adrenergic receptor trans-
duction pathway, have been more recently examined.46
Specifically, a left ventricular myocardial biopsy speci-
men taken at the time of cardiac surgery can be used to
isolate myocytes and measure contractile performance. It
has been shown that viable, quiescent isolated human
left ventricular myocytes can be obtained from this
application and have the ability to respond to electrical
stimulation in an appropriate manner (Fig 5). Moreover,
these left ventricular isolated myocyte preparations can
provide a means of studying the contractile effects of b -
adrenergic receptor stimulation. As shown in Fig 5, b -
adrenergic receptor stimulation (25 nm isoproterenol) of
normal isolated left ventricular myocytes produced an
inotropic response consistent with the physiologic
effects of b -receptor transduction. It is likely that these
isolated myocyte studies will provide important insight
into the mechanisms that regulate the excitation-contrac-
tion coupling process in normal and pathologic condi-
tions relevant to the cardiothoracic surgeon. 
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